Phenotype-oriented anticoagulant therapy for sepsis: still a work in progress

Area of Science:

• Critical care medicine
• Hematology
• Pathophysiology of sepsis

Background:

• Coagulation disorders are prevalent in sepsis, significantly contributing to multiple organ dysfunction syndrome (MODS).
• Anticoagulant therapy is a potential strategy to prevent MODS, but patient selection remains a challenge due to sepsis heterogeneity.
• Recent research suggests classifying sepsis into distinct phenotypes may improve therapeutic outcomes.

Purpose of the Study:

• To review the characteristics of different septic phenotypes.
• To explore factors contributing to the controversy surrounding anticoagulant therapy in sepsis.
• To identify challenges in defining optimal candidates for anticoagulant treatment.

Main Methods:

• Literature review focusing on sepsis phenotypes and coagulation abnormalities.
• Analysis of existing clinical data and research on anticoagulant therapy in sepsis.
• Discussion of diagnostic markers like D-dimer and fibrin/fibrinogen degradation products (FDPs).

Main Results:

• Sepsis is a heterogeneous condition with distinct phenotypes.
• Coagulation activation is a critical factor in sepsis-induced MODS.
• Increased D-dimer and FDPs indicate dysfunctional coagulation, suggesting potential candidacy for anticoagulant therapy.

Conclusions:

• Defining septic phenotypes is crucial for personalized treatment strategies.
• Controversies in anticoagulant therapy stem from sepsis heterogeneity.
• Further research is needed to refine criteria for selecting septic patients for anticoagulant therapy.